Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Article :100538

    
• • ·Content

    Article :100539

    

• Editorial

  • ·Low number of patients qualifying for amyloid targeting immunotherapy

    Article :100516

    Frank Jessen

    Plan Plan

• Short communication

  • ·Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic

    Article :100476

    Anna Rosenberg, Alina Solomon, Alexandre Bonnard, Makrina Daniilidou, Göran Hagman, Anette Hall, Anna Matton, Ulf Öhlund-Wistbacka, Eric Westman, Miia Kivipelto

    Résumé Résumé Plan Plan   

• Brief report

  • ·Brain health navigation in a large integrated healthcare system

    Article :100471

    G.E. Cooper, S. Patton, D. Lockridge, S.W. Freeman, D. Drexler, K. Wasz

    Résumé Résumé Plan Plan  

• Original articles

  • ·No longitudinal association between hearing loss and Alzheimer’s disease pathology

    Article :100481

    Jordi H.C. Boons, Phuong Thuy Nguyen Ho, Anna van Houwelingen, M. Arfan Ikram, Gertjan Dingemanse, Bernd Kremer, Meike W. Vernooij, Andre Goedegebure, Julia Neitzel

    Résumé Résumé Plan Plan   
  • ·Associations of self- and informant-reported functional impairment with cognitive performance and incident dementia

    Article :100482

    Yaqing Gao, Paola Zaninotto, Andrew Steptoe

    Résumé Résumé Plan Plan   
  • ·Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease

    Article :100469

    James W. Kupiec, Anton P. Porsteinsson, Raymond S. Turner, Suzanne Hendrix, Craig Mallinckrodt, Arifulla Khan, Ian Cohen, Jonathan Liss, Roger Clarnette, Kee Hyung Park, Antonio M. Hernandez, Lindsay H. Burns

    Résumé Résumé Plan Plan   
  • ·Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease

    Article :100480

    Claude M Wischik, Richard Stefanacci, Peter Bentham, Serge Gauthier, Henrik Zetterberg, Gordon K Wilcock, Lutz Froelich, Alistair Burns, Emer MacSweeney, Clive Ballard, Jin-Tai Yu, Tay Siew Choon, Vahe Asvatourian, Natalia Muehlemann, Jan Priel, Karin Kook, Tenecia Sullivan, Diane Downie, Sonya Miller, Carol Pringle, John M. D Storey, Tom Baddeley, Charles R Harrington, Lewis K Penny, Mohammad Arastoo, Roger Staff, Anca-Larisa Sandu, Helen Shiells, Serena Lo, Nafeesa Nazlee, Emily Evans, Claire Hull, Bjoern O Schelter

    Résumé Résumé Plan Plan   

• Review

  • ·Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence

    Article :100473

    Lin Qi, Fangxue Zheng, Mengjiao Tu, Reema Abdullah, Yilei Zhao, Xinhui Su, Dan Zhou, Guoping Peng

    Résumé Résumé Plan Plan   

• Original articles

  • ·A regional framework for the detection and management of ARIA with anti-amyloid therapies in early Alzheimer’s disease in Asia

    Article :100477

    So Young Moon, Ta-Fu Chen, Bo-Ching Lee, Won Jin Moon, Nagaendran Kandiah, Sumeet Kumar, Young Ho Park, Kaori Inaba, Amitabh Dash

    Résumé Résumé Plan Plan  
  • ·The influence of bapineuzumab and semagacestat on rapid progressors: A retrospective cohort study

    Article :100483

    Kristofer Harris, Madison Shyer, Dulin Wang, Elizabeth He, Matias Cattani, Catherine Zhang, Christine M. Farrell, Xiaoqian Jiang, Yejin Kim, Paul E. Schulz

    Résumé Résumé Plan Plan   
  • ·Lecanemab over a two-year duration: Key insights from a regional specialty medical center

    Article :100489

    Lisa B.E. Shields, Hannah S. Hust, Gregory E. Cooper, Theresa Kluthe, Rachel N. Hart, Andrew P. Thaliath, Brandon C. Dennis, Stephanie W. Freeman, Jessica F. Cain, Whoy Y. Shang, Kendall M. Wasz, Adam T. Orr, Christopher B. Shields, Shirish S. Barve, Kenneth G. Pugh

    Résumé Résumé Plan Plan   
  • ·Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer’s disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort

    Article :100465

    Noelia Fandos, María Pascual-Lucas, Leticia Sarasa, Jose Terencio, Mª Eugenia Sáez, Juan Pablo Tartari, Ángela Sanabria, Oscar Sotolongo-Grau, Amanda Cano, Lluís Tárraga, Miren Jone Gurruchaga, Agustín Ruíz, Xavier Montalban, Mercè Boada, Montserrat Alegret, Marta Marquié, José Antonio Allué, on behalf of the FACEHBI study group, on behalf of the AMYPAD consortium, N. Aguilera, E. Alarcón-Martín, M. Alegret, J.A. Alllué, P. Bayón-Bujan, M. Berthier, J. Blázquez-Folch, M. Boada, M. Buendia, S. Bullich, F. Campos, B. Calm-Salvans, A. Cano, F. Casales, P. Cañabate, L. Cañada, C. Cuevas, I. de Rojas, S. Diego, G. Domingues-Kolinger, J.M. Escudero, A. Espinosa, N. Fandos, M.V. Fernández, A. Gailhajenet, P. García-González, J. Giménez, M. Gómez-Chiari, M. Guitart, M.J. Gurruchaga, P.C. Gutiérrez, I. Hernández, M. Ibarria, A. Lafuente, F. Lomeña, M. Marquié, E. Martín, C. Martínez, M. Martinez, A. Miguel, M. Moreno, A. Morera, L. Montrreal, N. Muñoz, A. Muñoz-Morales, A. Niñerola, A.B. Nogales, L. Núñez, C. Olivé, A. Orellana, G. Ortega, A. Páez, A. Pancho, E. Pelejà, E. Pérez-Martínez, A. Pérez-Cordon, V. Pérez-Grijalba, M. Pascual-Lucas, A. Perissinotti, S. Preckler, R. Puerta, M.I. Ramis, J.N. Rodríguez, N. Roé-Vellvé, J. Romero, M. Rosende-Roca, A. Ruiz, A. Sanabria, P. Sanz-Cartagena, L. Sarasa, S. Seguer, A. Solivar, O. Sotolongo-Grau, A. Stephens, J.P. Tartari, L. Tárraga, M.A. Tejero, J. Terencio, M. Torres, A. Valenzuela, S. Valero, L. Vargas, A. Vivas

    Résumé Résumé Plan Plan   
  • ·Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer’s disease pathology

    Article :100474

    Yonghong Li, Robert J. Lagier, Michael K. Racke, Yuri A. Fesko

    Résumé Résumé Plan Plan   
  • ·Head injury/traumatic brain injury and the risk of dementia: An observational and Mendelian randomization study

    Article :100468

    Ziyu Ouyang, Bin Jiao, Xuewen Xiao, Qijie Yang, Yuan Zhu, Lu Shen, Nan Li

    Résumé Résumé Plan Plan   
  • ·Preeclampsia as a reversible risk factor for Alzheimer’s disease: A prospective MRI study on morphological changes of the cerebral cortex and impairment of cognitive functions

    Article :100475

    Yuanyuan Wang, Meng Li, Tao Chen, Yanli Li, Qingqing Wang, Xinyue Zhang, Na Wang, Linfeng Yang, Lingfei Guo, Wenying Nie

    Résumé Résumé Plan Plan   

• Review

  • ·The liver as a metabolic and immune hub in Alzheimer’s disease: From mechanisms to therapeutic opportunities

    Article :100478

    Jiajie Chen, Luyao Wang, Yingying Zhou, Shuoyan Zhao, Qin Chen, Kai Zheng

    Résumé Résumé Plan Plan   

• Original articles

  • ·Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging

    Article :100479

    Ashwati Vipin, James Xiao Yuan Chen, Mervin Tee, Saima Hilal, Yi Jin Leow, Simon Konstandin, Klaus Eickel, Matthias Günther, Jan Petr, Henk JMM Mutsaerts, Nagaendran Kandiah

    Résumé Résumé Plan Plan  
  • ·Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration

    Article :100486

    Jesús García-Castro, Lawren VandeVrede, Michael C. Donohue, Lídia Vaqué-Alcázar, Sara Rubio-Guerra, Judit Selma-González, Hilary W. Heuer, Alejandra O. Morcillo-Nieto, María Franquesa, Oriol Dols-Icardo, Alexandre Bejanin, Olivia Belbin, Juan Fortea, Daniel Alcolea, Maria Carmona-Iragui, Carla Abdelnour, Isabel Barroeta, Miguel Santos-Santos, María Belen Sánchez Saudinós, Isabel Sala, Alberto Lleó, Maria Luisa Gorno-Tempini, Maria Luisa Mandelli, Rema Raman, Anne-Marie A Wills, Eden Barragan, Irene Litvan, Brad Boeve, Brad Dickerson, Murray Grossman, Edward D. Huey, David J. Irwin, Alex Pantelyat, Carmela Tartaglia, Julio C. Rojas, Adam L. Boxer, Ignacio Illán-Gala, Four Repeat Tau Neuroimaging Initiative (4RTNI) and the AL108-231 Investigators

    Résumé Résumé Plan Plan   
  • ·Association of plasma p-tau and p-tau/Aβ ratio with Alzheimer's pathology

    Article :100472

    Xuhui Chen, Mingxing Jiang, Laihong Zhang, Jiayi Zhu, Anqi Li, Zhengbo He, Xin Zhou, Yalin Zhu, Chen Zhang, Cong Wang, Mingxu Li, Yiying Wang, Xinyue Ma, Binhui Liu, Rong Ma, Yipeng Jin, Xiang Fan, Zhen Liu, Tengfei Guo, Yong-An Sun, Guoyu Lan

    Résumé Résumé Plan Plan   

• Review

  • ·Identifying risk factors of young-onset dementia and evaluating evidence hierarchy: a meta-analysis and umbrella review

    Article :100467

    Jiayu Zhang, Dandan Yang, Jian Liang, Yin Hu, Liping Rao, Jun Huang, Qijun Wu, Bo Jiang

    Résumé Résumé Plan Plan   

• Original article

  • ·Association between plasma metal element profiles and cognitive impairment in occupationally aluminum-exposed workers at a large aluminum plant in northern China

    Article :100470

    Xin Guo, Fangyu Gao, Mujia Li, Baolong Pan, Feng Gao, Shanshan Wang, Jingsi Zhang, Xiaoting Lu, Jing Song, Linping Wang, Huifang Zhang, Qiao Niu

    Résumé Résumé Plan Plan   

• The Clinical Trials on Alzheimer's Disease (CTAD) Advanced Workshop and Course in Azheimer's Disease Clinical Trials, September 6-7, 2025, Shanghai, China

  • ·CTAD China advanced workshop and course in AD clinical trials – Shanghai, September 6–7, 2025

    Article :100484

    Yong Shen, Xiaochun Chen, Jiong Shi

    Plan Plan
  • ·The Clinical Trials on Alzheimer’s Disease (CTAD) Advanced Workshop and Course in Azheimer’s Disease Clinical Trials, September 6-7, 2025, Shanghai, China, Oral communications

    Article :100505

    Plan Plan
  • ·The Clinical Trials on Alzheimer’s Disease (CTAD) Advanced Workshop and Course in Azheimer’s Disease Clinical Trials, September 6-7, 2025, Shanghai, China, Posters

    Article :100506

    Plan Plan